BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 09/09/2025

FDA Reopens Comment Period for M13B Bioequivalence Guidance

The FDA is extending the comment period for its draft guidance on bioequivalence for immediate-release solid oral dosage forms, allowing more time for public input.

Source: Federal Register — Food and Drug AdministrationOpen original release →